Chargement en cours...
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response()
Over the last decade we have witnessed the convergence of two powerful experimental designs toward a common goal of defining the molecular subtypes that underpin the likelihood of a cancer patient responding to treatment in the clinic. The first of these ‘experiments’ has been the systematic sequenc...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003351/ https://ncbi.nlm.nih.gov/pubmed/24607840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gde.2013.12.002 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|